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Review
The International Agency for Research on 
Cancer (IARC) classified benzene as a group 1 
carcinogen (carcinogenic to humans) in its 
1982 and 1987 evaluations (IARC 1982, 
1987) based primarily on reports of an asso-
ciation between occupational exposure to 
benzene and leukemia, particularly acute non-
lymphocytic leukemia (ANLL), which con-
sists primarily of acute myelogenous leukemia 
(AML). Recently, IARC updated its previous 
reviews of several chemicals and occupational 
exposure circumstances, including benzene, 
to reassess carcinogenicity and to consider 
potential associations with additional tumor 
sites (Baan et al. 2009). In that review, IARC 
determined for the first time that in addition 
to the confirmed association with ANLL, there 
was also limited evidence that benzene causes 
acute lymphocytic leukemia (ALL), chronic 
lymphocytic leukemia (CLL), non-Hodgkin 
lymphoma (NHL), and multiple myeloma 
(MM) in humans (Baan et al. 2009). At the 
same time, in recent years, there has been a 
plethora of reviews and meta-  analyses of ben-
zene and one or more lymphoid neoplasms, at 
times reaching diametrically opposed conclu-
sions (Alexander and Wagner 2010; Bergsagel 
et al. 1999; Infante 2006; Kane and Newton 
2010; Lamm et al. 2005; Savitz and Andrews 
1997; Schnatter et al. 2005; Smith et al. 2007; 
Sonoda et al. 2001; Steinmaus et al. 2008; 
Wong and Fu 2005; Wong and Raabe 1995, 
1997, 2000a, 2000b).
There are two fundamental challenges in 
using the large number of occupational cohort 
studies that have been published over the last 
30 or so years when considering the relation-
ship between occupational benzene exposure 
and the risk of lymphoid neoplasms. First, 
there have been substantial changes in testing 
procedures, diagnostic criteria, and categoriza-
tion of lymphoid neoplasms over the last half-
century (Aisenberg 2000; Harris et al. 2000; 
Linet et al. 2007; Morton et al. 2007), the 
time period in which follow-up of these occu-
pational cohorts took place. Indeed, diagnostic 
criteria that were used in these cohort studies 
were based on a range of classification strate-
gies, including the International Classification 
of Diseases (ICD), Revisions 7–9, and ICD 
for Oncology, Revision 3 (ICD-O3) (World 
Health Organization 1955, 1965, 1975, 
2000). The changing views on the categoriza-
tion of lymphoid neoplasms is illustrated by 
the current categorization of ALL and CLL as 
subtypes of NHL in the most recent World 
Health Organization disease classification 
(Swerdlow et al. 2008), although these enti-
ties have been reported separately from NHL 
in essentially all occupational cohort studies of 
benzene-exposed workers. Second, there is het-
erogeneity in occupational cohort studies with 
regard to industry, sample size, documenta-
tion and level of benzene exposure, and docu-
mentation of the percentage of a given cohort 
that had true, nontrivial exposure to benzene. 
Inadequate documentation, uncertain quality 
of follow-up, and, most problematic, potential 
inclusion of “unexposed” workers in “exposed” 
categories would have likely resulted in attenu-
ation of the observed associations. Further, for 
the purpose of reviews or meta-  analyses, it can 
be challenging to separate informative from 
potentially noninformative cohorts in the face 
of uncertain documentation of key epidemio-
logical study design and exposure assessment 
characteristics.
Given the changing nature of the diagno-
sis of lymphoid neoplasms over time and the 
heterogeneity of occupational benzene cohort 
study quality in the literature, it is a chal-
lenge to discern the nature of the relationship 
between benzene and lymphoid neoplasms. 
To address this issue, we developed three 
strategies that we employ in a set of meta-
  analyses of occupational cohort studies for 
five lymphoma categories defined according 
to ICD-9: Hodgkin lymphoma (HL; ICD-9 
code 201), NHL (ICD-9 200, 202), MM 
(ICD-9 203.0), ALL (ICD-9 204.0), and 
CLL (ICD-9 204.1).
We applied the first strategy to assess the 
potential impact of the gradual increase in the 
quality of hematologic diagnoses over the last 
decades. This strategy involved stratification 
of the studies in the meta-  analyses based on 
the reported start of follow-up. We used the 
year 1970 as a cutoff point for stratification 
(approximate midpoint of follow-up of all 
studies included in this analysis). We based 
the second strategy on the established strong 
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association between benzene and AML. We 
argue that any study that was not able to 
detect at least a suggestive association between 
benzene and AML most likely had serious 
methodologic limitations in one or more 
aspects of study design. Examples of possible 
limitations are trivial exposure to benzene in 
the studied cohort, inclusion of “unexposed” 
workers in “exposed” categories or flaws in the 
assessment (or categorization) of health effects 
(Goldstein and Shalat 2000). Therefore, we 
used the direction and significance level of 
a reported association between benzene and 
AML as proxies for the overall study quality 
(AML significance level).
We based the third strategy on the evalu-
ation of the quality of the exposure assess-
ment carried out in each cohort. High-quality 
exposure assessment is essential to discrimi-
nate exposed individuals from nonexposed 
individuals (Vlaanderen et al. 2008). We 
assigned an exposure assessment quality clas-
sification to each study based on an a priori 
defined classification scheme and used this 
classification as an additional proxy of study 
quality, reasoning that those cohort studies 
with the highest quality exposure assessment 
had the greatest ability to identify and include 
workers who were truly exposed to benzene in 
their analyses.
We hypothesized that application of the 
three study quality dimensions—stratification 
based on the start of follow-up, AML signifi-
cance level, and exposure assessment quality—
would identify a subgroup of occupational 
cohort studies that is most informative for the 
evaluation of the possible association between 
benzene and lymphoid neoplasms.
Materials and Methods
Study identification and data extraction. 
We conducted a search of PubMed (http://
www.ncbi.nlm.nih.gov/sites/entrez) using the 
key words “benzene” and “cohort” or “case–
control.” We included publications in the 
meta-  analysis if they were published in the peer-
reviewed literature, reported results for any of 
the five lymphoma subtypes (HL, NHL, MM, 
ALL, and CLL), and were conducted in the 
occupational setting. We checked references in 
all identified publications for additional studies. 
When more than one paper was published on 
the same cohort, we chose the publication with 
the highest quality exposure assessment [e.g., 
in the Australian petroleum workers cohort for 
AML, we chose the nested case–control study 
that included an elaborated exposure assess-
ment approach (Glass et al. 2003) over a more 
recent update on the full cohort that included 
no detailed benzene exposure assessment (Gun 
et al. 2006)]. When multiple publications with 
similar quality of exposure assessment were 
published on the same cohort, we chose the 
most recent update (with the longest follow-up 
time). In this meta-  analysis, we pooled risk 
ratios, odds ratios (ORs), and standardized 
mortality ratios (SMRs). ORs and SMRs can 
be interpreted as reasonable approximations of 
the risk ratio when the disease is rare, and these 
measures have been pooled with risk ratios for 
meta-  analyses before (McElvenny et al. 2004). 
We use the term “relative risk” (RR) to refer 
to the risk ratio, the OR, or the SMR. We 
extracted RRs based both on incidence and 
mortality. However, if a publication reported 
both, we chose incidence over mortality in the 
meta-  analysis.
Risk estimates. To allow the inclusion of 
studies without quantitative exposure assess-
ment in our analysis, we used only RRs for 
“any occupational benzene exposure” versus 
“background benzene exposure” in the meta-
  analyses. If publications reported only RRs 
stratified for cumulative exposure and not for 
“any occupational benzene exposure” versus 
“background benzene exposure,” we pooled 
RRs by summing observed and expected cases 
for studies that reported SMRs (percentage of 
RRs: AML, 4.8%; HL, 3.7%; NHL, 3.0%; 
MM, 3.8%; CLL, 5.6%) or by conducting a 
within-study random-effects meta-  analysis of 
the nonreference exposure groups for stud-
ies that reported RRs or ORs (percentage of 
RRs: AML, 14.3%; NHL, 3.0%; MM, 7.7%; 
ALL, 5.9%; CLL, 16.7%). If publications 
reported only observed and expected number 
of cases and no RRs, we calculated RRs and 
estimated associated confidence intervals (CIs) 
with mid-P exact (Rothman and Boice 1979) 
(percentage of RRs: AML, 4.8%; HL, 7.4%; 
ALL, 17.6%). For publications that reported 
no observed cases for any of the lymphoma 
subtypes, we calculated continuity corrected 
RRs (observed and expected number of cases 
plus one) and we estimated associated CIs 
with mid-P exact (percentage of RRs: ALL, 
11.8%; HL, 11.1%). If studies reported zero 
for the lower CI, we imputed a value of 0.1 to 
allow estimation of the variance (percentage 
of RRs: ALL, 5.9%; MM, 3.8%).
Three strategies for the assessment of study 
quality dimensions. We stratified by the year 
of start of follow-up based on the informa-
tion provided in the included publications 
(follow-up started before 1970 vs. follow-up 
started in or after 1970). The median start 
of follow-up in the stratum with studies that 
started follow-up before 1970 was 1947, and 
the median start of follow-up in the stratum 
with studies that started follow-up in 1970 or 
after was 1973.
We assigned AML significance level to 
each publication based on a two-sided p-value 
of the z-score, which we estimated by dividing 
the reported log RR for AML by its standard 
error. Based on the calculated AML signifi-
cance level, we assigned one of the following 
categories (A–E) to each publication: A, AML 
RR > 1, p < 0.1; B, AML RR > 1, 0.1 ≤ p 
< 0.2; C, AML RR > 1, p ≥ 0.2; D, AML RR 
≤ 1; E, no AML RR reported.
We assigned quality of exposure assess-
ment (A–D) to each publication as follows: A, 
in the publication explicit quantitative expo-
sure estimates for benzene were reported; B, 
in the publication semiquantitative estimates 
of benzene exposure or quantitative estimates 
of exposures containing benzene (e.g., gaso-
line) were reported; C, in the publication 
some industrial hygiene sampling results to 
indicate that benzene exposure was present 
in the cohort that was studied were reported; 
D, the publication qualitatively indicated that 
benzene exposure was present in the cohort.
Statistical analyses. We conducted random-
effects meta-  analyses to pool the RRs reported 
in the included publications. We used an α 
of 0.05 to assess whether meta-relative risks 
(mRRs) were significantly elevated. We con-
ducted the first set of meta-  analyses on the full 
set of studies stratified for the start of follow-up 
(follow-up started before 1970 vs. follow-up 
started in or after 1970). We compared mRRs 
by strata using a test of interaction as suggested 
by Altman and Bland (2003).
We applied the study quality dimensions 
of AML significance level and quality of expo-
sure assessment in two series of meta-  analyses. 
The initial analysis in each series included 
all studies regardless of quality. In each sub-
sequent analysis, we excluded the group of 
studies with the lowest AML significance level 
or the lowest quality of exposure assessment.
We used Cochran’s Q-test to assess 
between study heterogeneity in all meta-
  analyses. A p-value < 0.1 was considered to be 
statistically significant evidence for between 
study heterogeneity. We used I2 to describe 
the percentage of total variation across stud-
ies that was due to heterogeneity rather than 
chance (Higgins et al. 2003). For analyses 
that displayed significant between study 
hetero  geneity, we assessed the sensitivity of 
the outcome of the meta-  analysis for indi-
vidual studies by excluding studies one at the 
time (jackknife analysis). We assessed publica-
tion bias with Eggers graphical test (Egger 
et al. 1997). We performed all meta-  analyses 
in Stata (version 11; StataCorp LP, College 
Station, TX, USA).
Results
We identified 44 publications that provided 
an RR for at least one of the lymphoma 
subtype–specific meta-  analyses. We did not 
extract data from three publications: one 
study with likely underascertainment of can-
cer deaths as the result of the inability to iden-
tify the type of cancer for a number of cancer 
deaths (Infante 2005; Sorahan et al. 2005); 
one study for which we could not estimate 
the RR variance [a nested case–control study Occupational benzene and lymphoma subtypes
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that did not report CIs (Ott et al. 1989)]; 
and one study that reported proportionate 
mortality ratios, which tend to underestimate 
the RR (Thomas et al. 1982). Table 1 lists all 
publications that contributed to the meta-
  analyses, their (assigned) cohort name, the 
(assigned) name of the subcohort (if relevant), 
the literature reference, the type of industry in 
which the study was performed, the follow-up 
period, the lymphoma subtype for which the 
publication was included (if reported with 
ICD code and revision), an indicator of 
whether RRs were based on incidence or mor-
tality, the assigned AML significance level, 
and the assigned quality of exposure assess-
ment. The earliest included publication dates 
from 1983, and the most recent publication 
was from 2008. For two cohorts we used non-
peer-reviewed publications to extract RRs 
for MM (and NHL) that were not reported 
in the peer-reviewed publications (Atkinson 
et al. 2001; Delzell E, Sathiakumar N, Cole P, 
Brill I, unpublished report). Both reports 
were based on the exact same methodology 
and follow-up time as reports of these cohorts 
that appeared in the peer-reviewed literature 
(Glass et al. 2003; Sathiakumar et al. 1995). 
We included an RR for MM from a study 
by Decoufle et al. (1983) based on additional 
information that was reported in the preamble 
to the final Occupational Safety and Health 
Administration (OSHA) benzene standard 
of 1987 (OSHA 1987). We extracted NHL 
Table 1. Overview of publications included in the meta-  analyses.
Cohort Subcohort Reference Industry
Follow-up 
period Included for outcomes (ICDa)
ICD 
revisiona,b I/Mc
AML 
significance 
leveld
Exposure 
assessment 
qualitye
Australian petroleum 
workers cohort
Atkinson et al. 
2001f
Petroleum industry 1980–1998 MM (203) 9 I C A
Australian petroleum 
workers cohort
  Glass et al. 2003 Petroleum industry 1980–1998 AML (205.0, 208.0), CLL (204.1) 9 I C A
Australian petroleum 
workers cohort
  Gun et al. 2006 Petroleum industry 1981–1999 ALL (204.0), NHL (200–202) 9 I C D
Beaumont, Texas, 
petroleum refinery cohort
  Wong et al. 
2001a
Petroleum industry 1945–1996 ALL (204.0), AML (205.0), CLL (204.1), 
MM (203), NHL (200, 202), HL (*)
8 M C D
Canadian petroleum 
company cohort
  Schnatter et al. 
1996
Petroleum industry 1964–1983 MM (203), NHL (200, 202.0, 202.1, 
202.2, 202.9)
8 M E A
Canadian petroleum 
company cohort
  Lewis et al. 2003 Petroleum industry 1964–1994 ALL (204.0), AML (205.0), CLL 
(204.1), HL (201)
9 I D D
Caprolactam workers   Swaen et al. 
2005
Chemical industry 1951–2001 MM (31), HL (29) B M E A
Conoco chemical plant 
cohort
  Decoufle et al. 
1983
Chemical industry 1947–1977 MM (*) 8 M E D
Dow cohort   Bloemen et al. 
2004
Chemical industry 1940–1996 AML (205.0, 206.0, 207.0), 
CLL (204.1), MM (203), NHL 
(200.0–200.8, 202.0, 202.8), HL (201)
9 M C A
Exxon cohort Louisiana Huebner et al. 
2004
Petroleum industry 1970–1997 ALL (204.0), AML (205.0, 206.0, 
207.0, 207.2), CLL (204.1), MM 
(203.0), NHL (200.0–200.2, 200.8, 
202.0–202.2, 202.8–202.9), HL (201)
9 M B D
Exxon cohort Texas Huebner et al. 
2004
Petroleum industry 1970–1997 ALL (204.0), AML (205.0, 206.0, 
207.0, 207.2), CLL (204.1), MM 
(203.0), NHL (200.0–200.2, 200.8, 
202.0–202.2, 202.8–202.9) HL (201)
9 M A D
Finnish oil refinery workers   Pukkala 1998 Petroleum industry 1967–1994 NHL (*), HL (*) (*) I E D
French gas and electric 
utility workers
  Guenel et al. 
2002
Gas and electric 
utility industry
1978–1989 ALL (*), AML (*), CLL (*) O  I D B
Italian oil refinery   Consonni et al. 
1999
Petroleum industry 1949–1991 NHL (200, 202), HL (201) 8 M E D
Martinez and Wilmington 
refinery and petrochemical 
plants, California
  Tsai et al. 1993 Petroleum industry 1973–1989 NHL (200), HL (201) 8 M E D
Monsanto cohort   Collins et al. 
2003
Chemical industry 1940–1999 AML (205.0, 206.0), CLL (204.1), MM 
(203), NHL (200, 202), HL (201)
8 M A A
NCI-CAPM   Yin et al. 1996 Multiple industries 1972–1987 ALL (*), MM (*) 9 I A A
NCI-CAPM   Hayes et al. 
1997
Multiple industries 1972–1987 AML (205.0, 206.0, 207.0), NHL 
(200, 202)
9 I A A
Norway upstream 
petroleum industry
  Kirkeleit et al. 
2008
Petroleum industry 1981–2003 ALL (*), AML (*), CLL (*), MM (*), 
NHL (*), HL (*)
7 I A D
Paulsboro, New Jersey, 
refinery (Mobil)
  Collingwood 
et al. 1996
Petroleum industry 1946–1987 NHL (200), HL (201) 8 M E D
Petrochemical workers, 
Texas City, Texas
  Waxweiler et al. 
1983
Petroleum industry 1941–1977 NHL (200), HL (201) 7 M E D
Petroleum manufacturing 
plant, Illinois, USA (Shell)
  McCraw et al. 
1985
Petroleum industry 1973–1982 ALL (*), AML (*), CLL (*) 8 M A D
Petroleum manufacturing 
plant, Illinois, USA (Shell)
  Honda et al. 
1995
Petroleum industry 1940–1989 NHL (*), HL (*) 9 M E  D
Pliofilm cohort   Wong 1995 Chemical industry 1940–1987 AML (C) C M A A
Pliofilm cohort   Rinsky et al. 2002 Chemical industry 1950–1996 NHL (C), MM (C) C M E  A
Port Arthur, Texas, refinery 
workers
  Satin et al. 1996 Petroleum industry 1937–1987 ALL (204.0), AML (205.), CLL (204.1), 
MM (203), NHL (200, 202), HL (201)
8 M D D
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RRs for two studies by Wong and colleagues 
(Wong 1987a; Wong et al. 1993) from Wong 
(1998), a letter that provided results from 
additional analyses for these studies. Finally, 
there might have been a slight (nonidentifi-
able) overlap in the cohorts studied by Wong 
(1987a, 1987b) and Collins et al. (2003).
Table 2 shows the mRR based on random-
effect meta-  analyses for all studies and strati-
fied by start of follow-up for AML and the five 
lymphoma subtypes (i.e., HL, NHL, MM, 
ALL, and CLL). The overall mRRs (95% CIs) 
for AML and ALL were significantly increased 
[mRR = 1.68 (1.35–2.10) and mRR = 1.44 
(1.03–2.02), respectively]. The overall mRR 
for MM and CLL were slightly but not signif-
icantly elevated, whereas the overall mRRs for 
HL and NHL were close to unity. Stratified 
analyses by start of follow-up showed higher 
RRs for AML, NHL, and CLL for studies 
with a follow-up starting in or after 1970 than 
for studies that started the follow-up before 
1970 (p < 0.10). We observed no significant 
difference in mRR between the follow-up 
strata for HL, MM, and ALL. We observed 
significant between-study heterogeneity for 
AML, NHL, and CLL overall and in the 
studies with start of follow-up before 1970 
[see Supplemental Material, Figure 1 
(doi:10.1289/ehp.1002318)]. Exclusion of 
the most influential studies/RRs (based on 
the distance of the RR to the mRR and the 
weight of the study) resulted in mRRs that 
were essentially similar (data not shown).
Table 3 shows mRRs based on random-
effects meta-  analyses stratified by AML sig-
nificance level for AML, HL, NHL, MM, 
ALL, and CLL. As could be expected, the lym-
phoma mRRs based on only the studies that 
Table 1. continued
Cohort Subcohort Reference Industry
Follow-up 
period Included for outcomes (ICDa)
ICD 
revisiona,b I/Mc
AML 
significance 
leveld
Exposure 
assessment 
qualitye
Richmond and El Segundo 
refineries
  Dagg et al. 1992 Petroleum industry 1950–1986 NHL (200), HL (201) 8 M E D
Sample of U.S. refineries   Kaplan 1986 Petroleum industry 1972–1980 MM (*), HL (*) (*) M E D
Service station workers in 
Nordic countries
  Lynge et al. 1997 Service station 
workers
1970–1990 AML (*), CLL (*), MM (203), NHL 
(200, 202), HL (201)
7 I C C
Shell Deer Park refinery   Tsai et al. 1996 Petroleum industry 1948–1989 NHL (200), HL (201) 8 M E D
Shell Louisiana refinery   Tsai et al. 2003 Petroleum industry 1973–1999 NHL (200), HL (201) 8 M E D
Shoe workers cohort Italian 
cohort
Fu et al. 1996 Shoe workers 1950–1990 MM (203), NHL (200, 202) 9  M E D
Shoe workers cohort U.K. cohort Fu et al. 1996 Shoe workers 1939–1991 MM (203), NHL (200, 202) 9 M E D
Swedish seamen working 
on product or chemical 
tankers
  Nilsson et al. 
1998
Petroleum tanker 
workers
1971–1978 MM (203), NHL (200, 202), HL (201) 8 I E D
Texaco crude oil workers   Divine and 
Hartman 2000
Petroleum workers 1946–1994 ALL (*), AML (*), CLL (*), MM (*), 
NHL (*), HL (201)
8 M A D
Texaco mortality study   Divine et al. 
1999a
Petroleum industry 1947–1993 HL (201) 8 M C D
Texaco mortality study   Divine et al. 
1999b
Petroleum industry 1947–1993 ALL (*), AML (*), CLL (*), MM (*), 
NHL (*)
8 M C D
Torrance, California, 
petroleum refinery
  Wong et al. 
2001b
Petroleum industry 1959–1997 ALL (204.0), AML (205.0), CLL 
(204.1), MM (203), NHL (200, 202), 
HL (*)
8 M D D
U.K. oil distribution and oil 
refinery workers
Refinery Rushton 1993 Petroleum industry 1950–1989 ALL A M D D
U.K. oil distribution and oil 
refinery workers
Distribution Rushton 1993 Petroleum industry 1950–1989 ALL A M C D
U.K. oil distribution and oil 
refinery workers
  Rushton and 
Romaniuk 1997
Petroleum industry 1950–1993 AML (*), CLL (*) 9 M A A
U.K. oil distribution and oil 
refinery workers
Refinery Sorahan 2007 Petroleum industry 1951–2003 MM (203), NHL (200, 202), HL (201) 9 M E D
U.K. oil distribution and oil 
refinery workers
Distribution Sorahan 2007 Petroleum industry 1951–2003 MM (203), NHL (200, 202), HL (201) 9 M E D
Union Oil Company cohort Oil and gas 
division
Delzell et al. 
1992f
Petroleum industry 1976–1990 MM (203), NHL (200, 202) 9 M A D
Union Oil Company cohort Refining 
division
Delzell et al. 
1992f
Petroleum industry 1976–1990 MM (203), NHL (200, 202) 9 M E D
Union Oil Company cohort Oil and gas 
division
Sathiakumar 
et al. 1995
Petroleum industry 1976–1990 AML (*) 9 M A D
U.S. chemical workers   Wong 1987a Chemical industry 1946–1977 HL (201) 8 M E A
U.S. chemical workers   Wong 1987b Chemical industry 1946–1977 MM (203) 8 M E A
U.S. chemical workers Wong 1998 Chemical industry 1946–1977 NHL (200, 202) 8 M E A
U.S. gasoline distribution 
employees
Land based Wong et al. 
1993
Petroleum industry 1946–1986 ALL (*), AML (*), CLL (*) 8 M B B
U.S. gasoline distribution 
employees
Marine Wong et al. 
1993
Petroleum industry 1946–1986 ALL (*), AML (*), CLL (*) 8 M D B
U.S. gasoline distribution 
employees
Land based 
and marine
Wong 1998 Petroleum industry 1946–1986 NHL (200, 202) 8 M C B
NCI-CAPM, National Cancer Institute–Chinese Academy of Preventive Medicine. 
a(*), ICD revision or specific ICD code was not reported. bA, deaths were coded according to a system developed by Statistics Netherlands (CBS); B, deaths were coded according to 
National Institute for Occupational Safety and Health life-table analysis system death categories; C, deaths were coded according to the ICD in effect at time of death. cI, incidence; 
M, mortality. dA, AML RR > 1, p < 0.1; B, AML RR > 1, 0.1 ≤ p < 0.2; C, AML RR > 1, p ≥ 0.2; D, AML RR ≤ 1; E, AML RR not reported. eA, quantitative exposure estimates for benzene; B, 
semiquantitative estimates of benzene exposure or quantitative estimates of exposures containing benzene; C, some industrial hygiene sampling results; D, qualitative indication that 
benzene exposure had occurred. fNon-peer-reviewed publication.Occupational benzene and lymphoma subtypes
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reported an RR for AML (A–D) are largely 
similar to the mRRs based on all the studies 
(A–E). These studies therefore provide a rela-
tively unbiased representation of the full set of 
studies. All outcomes except HL demonstrated 
an increase in mRRs with increasing AML 
significance level. However, the 95% CIs suc-
cessively widened as a result of the reduced 
number of studies/RRs that were retained 
with each increase in AML significance level. 
The increase in mRR was most pronounced 
for MM and ALL, and somewhat weaker for 
NHL and CLL. In contrast, the mRR for HL 
dropped with increasing AML significance 
level. We observed significant between-study 
heterogeneity for NHL and CLL in the sub-
set of studies with AML significance level A 
(p < 0.10) [see Supplemental Material, Figure 2 
(doi:10.1289/ehp.1002318)]. Jackknife analy-
sis eliminating one study at the time demon-
strated that, in the NHL analysis of the studies 
with AML significance level A, the RRs from 
Divine and Hartman (2000) and Delzell et al. 
(unpublished report) had considerable impact 
on the between-study heterogeneity. Exclusion 
of both RRs from this analysis resulted in a 
slight decrease in the mRR (95% CI) from 
1.16 (0.77–1.76) to 1.12 (0.77–1.61), with 
an I2 (an estimate of the percentage of total 
variation across studies that was due to het-
erogeneity rather than chance) of 22.8% (p = 
0.27). In the CLL analysis of the studies with 
AML significance level A, the RRs provided 
by Divine and Hartman (2000) and Rushton 
and Romaniuk (1997) appeared to be primar-
ily responsible for the observed between-study 
heterogeneity. Exclusion of both RRs from 
the meta-  analysis resulted in a slight decrease 
in the mRR from 1.39 (0.65–2.96) to 1.26 
(0.65–2.43), with an I2 of 0% (p = 0.94).
Table 4 shows mRRs based on random-
effects meta-  analyses and stratified by quality 
of exposure assessment. mRRs for NHL, MM, 
and CLL increased with increasing quality of 
exposure assessment. The increase in mRR was 
most pronounced for MM and CLL. Forest 
plots for AML and the five lymphoma subtypes 
for all studies with quality of exposure catego-
ries A and B (A, quantitative exposure estimates 
for benzene; B, semiquantitative estimates of 
benzene exposure or quantitative estimates of 
exposures containing benzene) are shown in the 
Supplemental Material, Figure 3 (doi:10.1289/
ehp.1002318). Jackknife analysis eliminating 
one study at the time demonstrated that in the 
set of studies with quality of exposure catego-
ries A and B, the RRs provided by Wong et al. 
(1993) (land-based cohort) and Rushton and 
Romaniuk (1997) had considerable impact on 
the observed between-study heterogeneity in the 
CLL analysis. Exclusion of both RRs from the 
meta-  analysis resulted in a slight decrease in the 
mRR (95% CI) from 1.54 (0.72–3.31) to 1.46 
(0.79–2.72), with an I2 of 0% (p = 0.43). The 
RR provided by Wong (1998) (gasoline distri-
bution employees) had a considerable impact 
on the observed between study heterogeneity in 
the NHL analysis of the set of studies in quality 
of exposure categories A and B. Exclusion of 
this RR resulted in a slight increase in the mRR 
from 1.04 (0.63–1.72) to 1.27 (0.90–1.79), 
with an I2 of 0% (p = 0.78).
Cross-stratification of AML significance 
level and quality of exposure assessment with 
the stratification based on the start of fol-
low-up, although limited by a loss of statisti-
cal power, showed that mRR patterns with 
increasing AML significance level and qual-
ity of exposure assessment [see Supplemental 
Material, Tables 1,2 (doi:10.1289/ehp. 
1002318)] were generally consistent with the 
patterns observed when meta-  analyses were 
stratified by start of follow-up (Table 2).
Table 2. mRRs (95% CIs) for AML and five lymphoma subtypes in cohort studies of workers exposed to benzene: stratification by start of follow-up.
All studies Start follow-up before 1970 Start follow-up in or after 1970
Test for 
difference by 
follow-up strata 
(p-value)a
Lymphoma 
subtype n studies
n exposed 
cases mRR n studies
n exposed 
cases
mRR (start follow-up 
 before 1970) n studies
n exposed 
cases
mRR (start follow-up 
1970 and later)
AML 21 217 1.68 (1.35–2.10)* 12 119 1.43 (1.07–1.92)* 9 98 2.08 (1.59–2.72) 0.06
HL 27 146 0.99 (0.83–1.19) 19 123 1.01 (0.83–1.23) 8 23 0.91 (0.59–1.40) 0.67
NHLb 33 647 1.00 (0.89–1.13)* 22 452 0.93 (0.81–1.06)* 11 195 1.21 (0.94–1.55)* 0.07
MM 26 284 1.12 (0.98–1.27) 16 204 1.07 (0.93–1.24) 10 80 1.26 (0.92–1.71) 0.35
ALL 17 47 1.44 (1.03–2.02) 10 30 1.30 (0.88–1.92) 7 17 1.92 (1.00–3.67) 0.31
CLL 18 111 1.14 (0.78–1.67)* 11 69 0.87 (0.50–1.50)* 7 42 1.63 (1.09–2.44) 0.07
aTest of interaction (Altman and Bland 2003). bNHL or lymphosarcoma/reticulosarcoma (preferred NHL if the study reported both). *Significant evidence for between study 
  heterogeneity (p < 0.1).
Table 3. mRRs (95% CIs) for AML and five lymphoma subtypes in cohort studies of workers exposed to 
benzene: stratification by AML significance level.
Lymphoma subtype
AML significance 
 levela n studies
n exposed  
cases mRR
AML A–E (all studies) 21 217 1.68 (1.35–2.10)*
A–D 21 217 1.68 (1.35–2.10)*
A–C 16 192 1.88 (1.56–2.27)
A–B 11 132 2.20 (1.77–2.72)
A 9 108 2.48 (1.94–3.18)
HL A–E (all studies) 27 146 0.99 (0.83–1.19)
A–D 12 69 0.99 (0.77–1.27)
A–C 9 39 0.82 (0.59–1.15)
A–B 5 7 0.47 (0.22–0.99)
A 4 7 0.50 (0.23–1.08)
NHLb A–E (all studies) 33 647 1.00 (0.89–1.13)*
A–D 15 383 0.97 (0.81–1.16)*
A–C 13 344 0.99 (0.81–1.21)*
A–B 7 130 1.21 (0.85–1.72)*
A 6 101 1.16 (0.77–1.76)*
MM A–E (all studies) 26 284 1.12 (0.98–1.27)
A–D 14 160 1.15 (0.95–1.40)
A–C 12 137 1.19 (0.94–1.49)
A–B 7 69 1.49 (1.13–1.95)
A 6 56 1.56 (1.11–2.21)
ALL A–E (all studies) 17 47 1.44 (1.03–2.02)
A–D 17 47 1.44 (1.03–2.02)
A–C 11 29 1.41 (0.90–2.19)
A–B 7 16 1.74 (0.90–3.36)
A 5 12 1.74 (0.77–3.90)
CLL A–E (all studies) 18 111 1.14 (0.78–1.67)*
A–D 18 111 1.14 (0.78–1.67)*
A–C 13 93 1.19 (0.74–1.90)*
A–B 8 57 1.37 (0.73–2.56)*
A 6 45 1.39 (0.65–2.96)*
aA, AML RR > 1, p < 0.1; B, AML RR > 1, 0.1 ≤ p < 0.2; C, AML RR > 1, p ≥ 0.2; D, AML RR ≤ 1; E, AML RR not reported. bNHL 
or lymphosarcoma/reticulosarcoma (preferred NHL if the study reported both). *Significant evidence for between study 
heterogeneity (p < 0.1).Vlaanderen et al.
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Egger’s test revealed no significant evi-
dence for publication bias in the data avail-
able for AML, HL, NHL, ALL, or CLL 
[see Supplemental Material, Figure 4 (doi: 
10.1289/ehp.  1002318)]. We observed evi-
dence for bias for MM (p = 0.03), but Egger’s 
test became nonsignificant after exclusion of 
all quality of exposure assessment studies in 
category D (p = 0.72).
Discussion
We conducted a series of meta-  analyses on 
occupational cohort studies to assess the pos-
sible association between benzene and lym-
phoid neoplasms. Using different dimensions 
of study quality, we report evidence for an 
association between occupational benzene 
exposure and lymphoma subtypes MM, ALL, 
and CLL. For these subtypes, mRRs increased 
with increasing study quality, regardless of the 
strategy that was used to assess study quality. 
mRRs for NHL also increased with increas-
ing study quality, although this effect was less 
pronounced. We did not observe an associa-
tion between occupational benzene exposure 
and HL. Importantly, with the exception of 
a chance finding, the increase in mRRs for 
NHL, MM, ALL, and CLL with increasing 
study quality most likely reflects an actual 
underlying association with at least some of 
these lymphoma subtypes.
Because we observed mRR patterns con-
sistent with a possible association between 
benzene and all lymphoma subtypes except 
HL, we formally explored quantitative expo-
sure–response relations for NHL, MM, ALL, 
and CLL, including all studies in quality of 
exposure assessment category A (studies with 
quantitative estimates of benzene exposure) 
based on flexible meta-regression analyses 
(Vlaanderen et al. 2009). The relatively lim-
ited number of studies in category A resulted 
in uncertain and unstable predictions of the 
exposure–response curve for NHL, MM, 
and CLL (data not shown). For ALL, only 
one study in quality of exposure assessment 
category A was available that precluded con-
ducting a meta-regression for this lymphoma 
subtype. Therefore, possible dose–response 
associations can only be discussed informally 
on a study-by-study basis.
Assessment of study quality dimensions. 
We developed three different quality dimen-
sions that reflect the substantial changes in 
diagnosis and categorization of lymphoid 
neoplasms over the last half century and the 
heterogeneity in occupational cohort studies 
with regard to industry, sample size, and doc-
umentation of benzene exposure. The gener-
ally higher RRs in the strata with studies that 
started follow-up in or after 1970 is consistent 
with better quality of lymphoma diagnosis in 
more recent years. The higher RRs are partic-
ularly noteworthy given that overall benzene 
exposure was likely reduced in workplaces 
after 1970–1980. Another secular trend in 
the quality of cohort studies over time was the 
greater use of incidence rather than mortality 
as end point (e.g., 91% of cohorts report-
ing CLL RRs with start of follow-up before 
1970 used mortality as the end point vs. 43% 
for studies with start of   follow-up in 1970 
or later). It is possible that for less aggres-
sive subtypes (e.g., CLL), subjects that died 
from other causes did not have lymphoma 
coded on their death certificate (Linet et al. 
2007). However, cross-stratification of results 
suggested that stratification by period of 
follow-up explained more of the observed 
heterogeneity than stratification by mortal-
ity/incidence (data not shown). Although it 
has been suggested that the RR for leuke-
mia subtypes observed in occupational studies 
might decrease with prolonged follow-up time 
(Richardson 2008), we found only modest 
evidence for this phenomenon for lymphoma 
subtypes. Substitution of the most recent RRs 
with those of previous updates did not mate-
rially change the results (data not shown).
Because the association between benzene 
and AML is established, we argue that a well-
conducted large epidemiologic study on ben-
zene and hemato- and lymphopoietic cancers 
should find such an association. If at least 
some evidence of association is not found, 
one could argue that there must be known 
or unknown methodologic limitations in the 
study design. Such studies would by extension 
most likely be noninformative regarding the 
association between benzene and lymphoid 
neoplasms. Naturally, one should realize that 
a failure to find evidence for an association 
could also be the result of insufficient statisti-
cal power. However, in our meta-  analyses we 
observed that the strong increase in mRRs for 
AML with increasing AML significance levels 
was generally paralleled by increasing mRRs 
in lymphoma subtypes. In other words, stud-
ies that reported higher (and more significant) 
RRs for AML generally also reported higher 
RRs for NHL, MM, ALL, and CLL.
The quality of exposure assessment has 
a large impact on the ability of an epidemi-
ological study to identify modest increased 
RRs. The relevance of our quality of expo-
sure assessment approach was illustrated with 
the strong increase in mRRs for AML with 
increasing quality of exposure assessment. 
This trend provides support for our assump-
tion that studies that conducted a more 
detailed benzene exposure assessment likely 
provide higher overall quality of evidence 
for the potential association of benzene with 
adverse health outcomes. Although one would 
expect that the study quality indicators for 
AML significance level and quality of expo-
sure assessment to be highly correlated, this 
is not necessarily the case. For instance, we 
did observe five studies in the lowest category 
quality of exposure assessment (D) that still 
reported a significant increased RR for AML, 
and we observed two studies from quality 
Table 4. mRRs (95% CIs) for AML and five lymphoma subtypes in cohort studies of workers exposed to 
benzene: stratification by exposure assessment quality.
Lymphoma subtype
AML significance  
levela n studies
n exposed  
cases mRR
AML A–D (all studies) 21 217 1.68 (1.35–2.10)*
A–C 10 108 1.73 (1.26–2.38)
A–B 9 95 1.82 (1.25–2.66)
A 6 71 2.32 (1.55–3.47)
HL A–D (all studies) 27 146 0.99 (0.83–1.19)
A–C 5 16 0.99 (0.58–1.71)
A–B 4 6 0.98 (0.36–2.67)
A 4 6 0.98 (0.36–2.67)
NHLb A–D (all studies) 33 647 1.00 (0.89–1.13)*
A–C 8 106 1.03 (0.70–1.51)*
A–B 7 69 1.04 (0.63–1.72)*
A 6 50 1.27 (0.90–1.79)
MM A–D (all studies) 26 284 1.12 (0.98–1.27)
A–C 9 37 1.15 (0.74–1.79)
A–B 8 28 1.48 (0.96–2.27)
A 8 28 1.48 (0.96–2.27)
ALL A–D (all studies) 17 47 1.44 (1.03–2.02)
A–C 4 11 1.26 (0.5–3.16)
A–B 4 11 1.26 (0.5–3.16)
A 1 5 2.80 (0.27–29.23)
CLL A–D (all studies) 18 111 1.14 (0.78–1.67)*
A–C 8 61 1.38 (0.71–2.69)*
A–B 7 53 1.54 (0.72–3.31)*
A 4 43 2.44 (0.88–6.75)
aA, quantitative exposure estimates for benzene; B, semiquantitative estimates of benzene exposure or quantitative 
estimates of exposures containing benzene; C, some industrial hygiene sampling results; D, qualitative indication that 
benzene exposure had occurred. bNHL or lymphosarcoma/reticulosarcoma (preferred NHL if the study reported both). 
*Significant evidence for between study heterogeneity (p < 0.1).Occupational benzene and lymphoma subtypes
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 2 | February 2011  165
of exposure assessment category B in the set 
of studies that reported an AML RR below 
unity (AML significance level category D). 
Therefore, the two study quality dimensions 
should be seen as complementary.
NHL. We observed a moderate increased 
RR of NHL with increasing study quality. 
However, neither the overall mRR nor any 
of the strata-specific mRRs reached formal 
statistical significance. Because our formal 
meta-regression did not result in robust dose–
response associations, we qualitatively explored 
exposure–response relations within each expo-
sure assessment quality category A publica-
tion that provided RRs for NHL. Of the six 
exposure assessment quality category A studies 
that reported RRs for NHL only one study 
reported a significant increased RR (p for trend 
< 0.02) with increasing cumulative exposure 
to benzene (Hayes et al. 1997). In contrast, in 
three of six publications the authors reported 
no clear trend of RRs for NHL with increas-
ing cumulative exposure to benzene (Bloemen 
et al. 2004; Collins et al. 2003; Schnatter et al. 
1996), whereas the remaining two publications 
did not report on the quantitative relation 
between NHL and cumulative exposure to 
benzene (Rinsky et al. 2002; Wong 1987a). In 
addition to these six studies, two publications 
that included MM in the definition of NHL 
did report on the quantitative relation of NHL 
plus MM and cumulative exposure to benzene 
(Glass et al. 2003; Wong 1987b). One of these 
studies reported an initial increase in RR with 
increasing exposure to benzene followed by a 
drop in RR in the upper cumulative exposure 
group (Wong 1987b), whereas the other study 
reported no association (Glass et al. 2003). 
We note, however, that a recent meta-  analysis 
including both case–control and cohort stud-
ies reported a significant elevated mRR for 
NHL when we restricted the analyses to the 
higher exposure groups and corrected for the 
healthy worker (inclusion) effect (Steinmaus 
et al. 2008).
Overall, the epidemiologic evidence for 
the association between NHL and benzene is 
conflicting. This is illustrated by three recent 
meta-  analyses that were based on largely the 
same data but reached a diametrically opposite 
conclusion on whether exposure to benzene is 
associated to NHL (Alexander and Wagner 
2010; Kane and Newton 2010; Steinmaus 
et al. 2008). The inconsistency in findings 
is partly explained by study quality and fail-
ure to correct for biases but might also to a 
certain extent be explained by the etiologic 
heterogeneity within this group of diseases. If 
some NHL subtypes [e.g., diffuse large B-cell 
lymphoma (DLBCL) or follicular lymphoma 
(FL)] are associated with benzene, but oth-
ers are not, any NHL RR will be attenuated 
because of the inclusion of non-benzene-as-
sociated NHL subtypes. This is even further 
complicated by the fact that the distribution 
of NHL subtypes may vary considerably from 
population to population, which could lead 
to significant variation in reported associa-
tions between potential risk factors and total 
NHL (Muller et al. 2005).
A series of recent population-based case–
control studies provide evidence that the 
association between some genetic and envi-
ronmental factors varies between major NHL 
subtypes such as DLBCL and FL (Lan et al. 
2009; Morton et al. 2008; Rothman et al. 
2006; Skibola et al. 2009, 2010). Another 
series of recent case–control studies that used 
relatively high-quality retrospective exposure 
assessment methods have provided evidence 
that this might also be true for the association 
between benzene and NHL subtypes (Cocco 
et al. 2010; Miligi et al. 2006; Wong et al. 
2009). The studies by Cocco et al. (2010) 
and Wong et al. (2009) reported a stronger 
association with benzene with FL [OR = 1.6 
(95% CI, 0.9–2.9) and OR = 7.00 (95% CI, 
1.45–33.70), respectively] than for DLBCL 
[OR = 0.9 (95% CI, 0.6–1.4) and OR = 0.66 
(95% CI, 0.31–1.42), respectively]. The study 
by Miligi et al. (2006) did not report an RR 
for FL (due to the limited number of cases) 
but reported an OR of 2.4 (95% CI, 1.3–4.5) 
for DLBCL.
MM. Our analyses are supportive of an 
association of benzene exposure with MM. 
mRRs increased considerably and reached 
near statistical significance regardless of the 
study quality dimension used except for 
the analyses stratified by AML significance 
level, where formal statistical significance was 
reached for the two highest quality strata. 
Our results are similar (albeit that the point 
estimates of the mRRs are slightly lower) to 
the results from a meta-  analysis by Infante 
(2006), in which slightly different inclusion 
criteria were applied [mRR = 2.13 (95% CI, 
1.31–3.46)]. Further evidence for an asso-
ciation between exposure to benzene and 
MM have been provided by two recent 
population-based case–control studies that 
reported increased MM RRs with increas-
ing exposure to benzene (Cocco et al. 2010; 
Seniori Costantini et al. 2008). We quali-
tatively explored the quantitative exposure–
response relation between benzene and MM. 
Two of eight exposure assessment quality cat-
egory A studies reported an increase in RR 
with increasing cumulative exposure (Collins 
et al. 2003; Rinsky et al. 2002); in two stud-
ies the authors reported no clear trend of RRs 
for MM with increasing cumulative exposure 
to benzene (Atkinson et al. 2001; Schnatter 
et al. 1996); and four studies did not report 
on the quantitative relation between cumula-
tive exposure to benzene and MM (Bloemen 
et al. 2004; Swaen et al. 2005; Wong 1987b; 
Yin et al. 1996). Therefore, although the 
evidence for an association between “any 
occupational benzene exposure” versus “back-
ground benzene exposure” and the RR of 
MM appears to be consistent, the evidence 
for an exposure–response relation between 
benzene and MM is more ambiguous. This 
would be explained partly by the much larger 
statistical power that is required to conduct 
quantitative   exposure–response analysis, often 
a complication for small-scale occupational 
cohort studies.
ALL. The association between exposure to 
benzene and ALL is difficult to study because 
the disease is rare in adults (Faderl et al. 2010). 
It is therefore noteworthy that our analyses 
do strongly suggest increased RRs for ALL. 
We were able to identify only two popula-
tion-based case–control studies that explored 
benzene–ALL associations in adults (Adegoke 
et al. 2003; Richardson et al. 1992). One case–
control study reported a (nonsignificantly) 
increased RR for ALL with a suggestion of 
an exposure–response relation (Adegoke et al. 
2003), whereas the other study did not observe 
any cases with ALL (Richardson et al. 1992). 
Together, the evidence from both cohort and 
case–control studies are strongly suggestive 
of a positive association between exposure to 
benzene and the RR of adult ALL.
CLL. Our analyses suggest that exposure 
to benzene is associated with an increased 
RR for CLL. This is in line with results from 
four recent case–control studies that reported 
RRs ranging from 1.4 to 2.05 (Cocco et al. 
2010; Miligi et al. 2006; Seniori Costantini 
et al. 2008; Wong et al. 2009). Two of these 
case–control studies reported an increase in 
RR with increasing benzene exposure (Cocco 
et al. 2010; Seniori Costantini et al. 2008). Of 
the cohort studies with quantitative exposure 
assessment, one study reported that the RR 
for the group with higher cumulative exposure 
was higher than the RR for the group with 
lower exposure (Glass et al. 2003). However, 
two cohort studies reported no association 
with cumulative exposure to benzene (Collins 
et al. 2003; Rushton and Romaniuk 1997), 
whereas one study did not report on the quan-
titative relation between cumulative exposure 
to benzene and CLL (Bloemen et al. 2004).
Conclusion
In line with the recent IARC evaluation of the 
carcinogenicity of benzene, our meta-  analyses 
provide evidence for the association of occu-
pational benzene exposure to MM, ALL, and 
CLL (Baan et al. 2009). Although these find-
ings are suggestive, it is important to realize that 
most analyses were based on data sets of limited 
size. The evidence for an association between 
benzene and NHL (as defined in ICD-9) is less 
convincing, but this could be explained by the 
heterogeneity in the association for particular 
subgroups of this disease or by not accounting Vlaanderen et al.
166  v o l u m e  119 | n u m b e r 2 | February 2011  •  Environmental Health Perspectives
for certain biases. We observed no association 
between benzene and HL. The discussion on 
the association between benzene and NHL 
will likely benefit from NHL subtype–specific 
analyses. Unfortunately, most current occu-
pational cohort studies lack sufficient statisti-
cal power to perform such detailed analyses. 
Cohort studies with central pathology review 
and well-designed case–  control studies using 
state-of-the-art retrospective exposure assess-
ment methods will be needed to help evalu-
ate the extent to which occupational benzene 
exposure is associated with specific subtypes 
of NHL.
Finally, our overall findings, taken together 
with the substantial experimental and molecu-
lar epidemiologic evidence that benzene expo-
sure alters key components of the immune 
system relevant for lymphomagenesis (e.g., 
CD4+ T-cell level and CD4+ T-cell:CD8+ 
T-cell ratio) (Lan et al. 2004), provide support 
that benzene is likely to be causally related to 
one or more subtypes of lymphoma.
cO R R e c t i O n
In the manuscript originally published 
online, data shown for the “AML signifi-
cance level” in Table 1 differed from the 
correct values used in the analysis due to 
a sorting error. In addition, one risk esti-
mate used in the meta-  analysis for NHL 
was classified incorrectly as “AML signifi-
cance level” C instead of as “AML signifi-
cance level” E. Correction of the “AML 
significance level” for this risk estimate 
resulted in minor changes in some of the 
meta relative risks reported in Table 3 and 
in Supplemental Material, Table 1. These 
errors have been corrected.
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